Press Releases Print Email
All Releases
View Summary Avanafil Clinical Data to Be Presented at European Association of Urology
Apr 11, 2014
PDF 14.0 KB Add to Briefcase
View Summary Three VIVUS Directors Not Standing for Re-Election
Apr 8, 2014
PDF 9.3 KB Add to Briefcase
View Summary VIVUS to Present at Upcoming Investor Conference
Apr 3, 2014
PDF 9.3 KB Add to Briefcase
View Summary Newly Published Review Article Summarizes Cardiovascular Benefit-Risk Profile of Qsymia
Mar 25, 2014
PDF 13.2 KB Add to Briefcase
View Summary Shari Belafonte Partners With VIVUS to Encourage Adults to Speak With Their Doctors About Losing Weight and Treatment Options Now Available
Mar 19, 2014
PDF 11.7 KB Add to Briefcase
View Summary VIVUS Reports Fourth Quarter and Year-End 2013 Financial Results
Feb 24, 2014
PDF 74.2 KB Add to Briefcase
View Summary VIVUS Announces Date of Fourth Quarter and Year End 2013 Financial Results and Conference Call
Feb 19, 2014
PDF 9.3 KB Add to Briefcase
View Summary VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (Avanafil)
Jan 21, 2014
PDF 18.0 KB Add to Briefcase
View Summary VIVUS Collaborates With Aetna to Test First Comprehensive Weight Management Program Integrating Weight Loss Medication
Jan 14, 2014
PDF 11.2 KB Add to Briefcase
View Summary VIVUS to Present at Upcoming Investor Conference
Jan 13, 2014
PDF 8.7 KB Add to Briefcase
View Summary VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia
Dec 12, 2013
PDF 13.1 KB Add to Briefcase
View Summary VIVUS to Present at Upcoming Investor Conference
Dec 2, 2013
PDF 8.7 KB Add to Briefcase
View Summary VIVUS Announces Support for New Obesity Treatment Guidance Urging Active Involvement From Healthcare Providers
Nov 21, 2013
PDF 12.6 KB Add to Briefcase
View Summary VIVUS Announces Issuance of Two Key U.S. Patents for Qsymia; Patent Coverage for Qsymia Extended to 2029
Nov 13, 2013
PDF 12.5 KB Add to Briefcase
View Summary VIVUS Announces Scientific Presentations
Nov 12, 2013
PDF 18.8 KB Add to Briefcase
View Summary VIVUS to Present at Upcoming Investor Conference
Nov 12, 2013
PDF 8.6 KB Add to Briefcase
View Summary VIVUS Reports Third Quarter and First Nine Months 2013 Financial Results
Nov 5, 2013
PDF 30.5 KB Add to Briefcase
View Summary VIVUS Announces Date of Third Quarter 2013 Financial Results and Conference Call
Nov 1, 2013
PDF 9.4 KB Add to Briefcase
View Summary Newly Published Study Finds Qsymia Achieves Greater Weight Loss at Lower Doses Than Either of Its Components as Monotherapy
Oct 31, 2013
PDF 13.5 KB Add to Briefcase
View Summary VIVUS, Inc. Announces License Agreement for the Marketing Rights to STENDRA in the United States and Canada
Oct 11, 2013
PDF 16.5 KB Add to Briefcase
Showing 1-20 of 368 Page: 1 2 3 ... 19  Next 20
= add release to Briefcase